Cannabidiol (CBD) Market

Global Cannabidiol (CBD) Market By Product Type (Isolate, Full Spectrum, And Broad Spectrum), By Source (Hemp, Marijuana), By Application (Anxiety, Fibromyalgia, Diabetes, And Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa)

  • Report ID: HC-27
  • Author: Growth Market Reports
  • Rating: 4.5
  • Total Reviews: 86
  • No. Of Pages: 733
  • Format:
  • Pub. Date: 2020-02-20
  • Share:

Market Outlook:

The global Cannabidiol (CBD) Market was valued at USD 395.2 Million in 2019 and is projected to reach USD 3,420.4 Million by 2027, expanding around a CAGR of 30.4% during the forecast period. Cannabidiol (CBD) is a naturally occurring chemical compound found in cannabis plants and accounts for 40% of plant extract. It is immiscible in water but miscible in organic solvents such as hexane or pentane. It is a colorless crystalline solid at room temperature and can be cyclized to Tetrahydrocannabinol (THC) under acidic conditions. CBD-based products such as oils, gums, supplements, and high concentration extracts are used for the treatment of many ailments such as anxiety, cognition, disturbed sleep, diabetes, and pain.

Cannabidiol (CBD) Market Size

Market Dynamics

Rising use of cannabis in several products due to increasing consumer preference for CBD products is fueling the growth of the market. Approval of pharmaceutical CBD products for several cancer patients to manage pain is driving market growth. Increasing usage of CBD in medical applications, skin care products, beverages, and supplements is anticipated to propel market growth. The growth of the market can be attributed to the substantial R&D and investments in the pharmaceutical industry. In term of consumption, market share of North America is growing due to the rise in use of CBD for medical purposes such as pain management. Moreover, legalization of CBD has eliminated the need for prescription. This, in turn, is expected to fuel market growth. Market players are creating their online selling platforms for the sale of products, which is boosting the sale of CBD, thus catapulting the market growth.

Segmental Outlook

On the basis of product type, the global Cannabidiol (CBD) Market is segmented as isolate, full spectrum, and broad spectrum. Isolate segment is anticipated to expand at a CAGR of around 30.5% during the forecast period as it produces cleaner and healthier oil as compared to alcohol extraction. Full spectrum segment is estimated to hold approximately 33.1% share of the market in 2020 as contains a complete range of cannabinoid and terpene profiles and provides high level of effectiveness. The broad spectrum segment is estimated to hold around 28.9% share of the market in 2021 offer a full range of cannabinoid profiles as it does not contain THC.

Cannabidiol (CBD) Market BPS Analysis

Based on source, the market is divided into hemp, marijuana. Hemp account for the major share as hemp derived CBD is obtained from industrial hemp plants, which are harvested for their seeds and fibers. CBD extracted from marijuana is consumed for its intoxicating properties. Correct products for consumers' needs can be found by experimenting with both by changing levels of THC and CBD.

Based on application, the market is segmented into anxiety, fibromyalgia, diabetes, and others. Anxiety account for the major share as to reduce the disorder. Traditional options for treating anxiety include prescription drugs, which can result in several major side effects; hence, people with anxiety can be treated with CBD oil.

Definitions

By Application

Anxiety

Anxiety is a type of feeling people experience when confronted with a threat, danger, or under stress. People feel upset, nervous, and tense when anxious. Anxiety disorders can be caused by various factors such as genetics, brain chemistry, and personality issues. Furthermore, anxiety can be a consequence of life experiences such as job loss, relationship failure, serious disease, major accident, or the death of a loved one. According to the Anxiety and Depression Association of America (ADAA), anxiety affects 40 million adults in the US aged 18 and above, or 18.1% of the population every year. Research has shown consumption of CBD oil by people with anxiety can significantly help to reduce the disorder. Traditional options for treating anxiety include prescription drugs, which can result in several major side effects; hence, people with anxiety can be treated with CBD oil.

Fibromyalgia

Fibromyalgia is an ailment characterized by musculoskeletal pain, fatigue, sleep, and mood and memory issues. General symptoms of fibromyalgia start after a physical trauma, infection, or significant psychological stress. Women are more prone to fibromyalgia than men. CBD can help relieve pain induced by fibromyalgia.

Diabetes

Diabetes is a chronic disease in which the body does not properly process food for use as energy. The body of a diabetic person does not produce enough insulin. This increases sugar or glucose in the blood and this can cause serious health-related issues including heart diseases, lower-extremity amputations, and kidney failure. Type 2 diabetes is an inflammatory disease and CBD can improve the condition as it possesses anti-inflammatory properties. Some research on CBD has shown a reduction in insulin resistance and blood sugars for type 2 diabetes patients. CBD oil can also be used for serious ailments such as cancer, and cerebral ischemia, and neuroprotection.

Cannabidiol (CBD) Market Analysis By Application

Regional Outlook

In terms of regions, the market is fragmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a promising region for the market. The region constituted approximately 50% share of the market in 2020. The market in the region is projected to expand at a CAGR around 29% during the forecast period as there is increase in demand for Cannabidiol (CBD) in Asia Pacific, increasing focus of players in development of Cannabidiol (CBD), rise in government initiatives are some of the factors expected to boost the market growth on the region.

Cannabidiol (CBD) Market Size By Region

Competitive Landscape

  • Key players in the market include Canopy Growth Corporation, Gaia Herbs, IRIE CBD, Isodiol International Inc, Aurora Cannabis, Cannoid, Inc., CBD American Shaman, CV Sciences, Inc., Elixinol, Endoca., FOLIUM BIOSCIENCES, Medical Marijuana, Inc., NuLeaf Naturals, LLC PharmaHemp.  These companies are considered manufacturers of Cannabidiol (CBD) based on their revenue, research development (R&D) activities, regional presence, and supply chain management system.

  • The players are adopting key strategies such as acquisition, and geographical expansion where potential opportunity for the Cannabidiol (CBD) is added in the company’s capacity.

  • In 2017, IRIE CBD completed the acquisition of IRIE which is a formulator of CBD products, adds another level of integration of vertically-integrated business model.

  • Jan. 9, 2020- Medical Marijuana, Inc. the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced that its investment company AXIM Biotechnologies, Inc. has signed a binding term sheet to acquire leading oncology research and development company Sapphire Biotech, Inc. as a wholly-owned subsidiary.

Cannabidiol (CBD) Market Analysis Share By Manufacturers


Key Benefits for Industry Participants & Stakeholders

  • In-depth Analysis of the Global Cannabidiol (CBD) Market

  • Historical, Current and Projected Market Size in terms of Value and volume

  • Potential & Niche Segments and Regions Exhibiting Promising Growth Covered

  • Industry Drivers, Restraints and Opportunities Covered in the Study

  • Recent Industry Trends and Developments

  • Competitive Landscape & Strategies of Key Players

  • Neutral Perspective on Global Cannabidiol (CBD) Market Performance

Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cannabidiol Market Overview
   4.1 Introduction
      4.1.1 Market Taxonomy
      4.1.2 Market Definition
      4.1.3 Macro-Economic Factors Impacting the Market Growth
   4.2 Cannabidiol Market Dynamics
      4.2.1 Market Drivers
      4.2.2 Market Restraints
      4.2.3 Market Opportunity
   4.3 Cannabidiol Market - Supply Chain Analysis
      4.3.1 List of Key Suppliers
      4.3.2 List of Key Distributors
      4.3.3 List of Key Consumers
   4.4 Key Forces Shaping the Cannabidiol Market
      4.4.1 Bargaining Power of Suppliers
      4.4.2 Bargaining Power of Buyers
      4.4.3 Threat of Substitution
      4.4.4 Threat of New Entrants
      4.4.5 Competitive Rivalry
   4.5 Global Cannabidiol Market Size & Forecast, 2017-2027
      4.5.1 Cannabidiol Market Size and Y-o-Y Growth
      4.5.2 Cannabidiol Market Absolute $ Opportunity
Chapter 5 Global Cannabidiol Market Analysis and Forecast By Product Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities By Product Type
      5.1.2 Basis Point Share (BPS) Analysis By Product Type
      5.1.3 Absolute $ Opportunity Assessment By Product Type
   5.2 Cannabidiol Market Size Forecast By Product Type
      5.2.1 Isolate
      5.2.2 Full Spectrum
      5.2.3 Broad Spectrum
   5.3 Market Attractiveness Analysis By Product Type
Chapter 6 Global Cannabidiol Market Analysis and Forecast By Source
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities By Source
      6.1.2 Basis Point Share (BPS) Analysis By Source
      6.1.3 Absolute $ Opportunity Assessment By Source
   6.2 Cannabidiol Market Size Forecast By Source
      6.2.1 Hemp
      6.2.2 Marijuana
   6.3 Market Attractiveness Analysis By Source
Chapter 7 Global Cannabidiol Market Analysis and Forecast By Application
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities By Application
      7.1.2 Basis Point Share (BPS) Analysis By Application
      7.1.3 Absolute $ Opportunity Assessment By Application
   7.2 Cannabidiol Market Size Forecast By Application
      7.2.1 Anxiety
      7.2.2 Fibromyalgia
      7.2.3 Diabetes
      7.2.4 Others.
   7.3 Market Attractiveness Analysis By Application
Chapter 8 Global Cannabidiol Market Analysis and Forecast by Region
   8.1 Introduction
      8.1.1 Key Market Trends & Growth Opportunities by Region
      8.1.2 Basis Point Share (BPS) Analysis by Region
      8.1.3 Absolute $ Opportunity Assessment by Region
   8.2 Cannabidiol Market Size Forecast by Region
      8.2.1 North America
      8.2.2 Europe
      8.2.3 Asia Pacific
      8.2.4 Latin America
      8.2.5 Middle East & Africa (MEA)
   8.3 Market Attractiveness Analysis by Region
Chapter 9 Coronavirus Disease (COVID-19) Impact
   9.1 Introduction
   9.2 Current & Future Impact Analysis
   9.3 Economic Impact Analysis
   9.4 Government Policies
   9.5 Investment Scenario
Chapter 10 North America Cannabidiol Analysis and Forecast
   10.1 Introduction
   10.2 North America Cannabidiol Market Size Forecast by Country
      10.2.1 U.S.
      10.2.2 Canada
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 North America Cannabidiol Market Size Forecast By Product Type
      10.6.1 Isolate
      10.6.2 Full Spectrum
      10.6.3 Broad Spectrum
   10.7 Basis Point Share (BPS) Analysis By Product Type
   10.8 Absolute $ Opportunity Assessment By Product Type
   10.9 Market Attractiveness Analysis By Product Type
   10.10 North America Cannabidiol Market Size Forecast By Source
      10.10.1 Hemp
      10.10.2 Marijuana
   10.11 Basis Point Share (BPS) Analysis By Source
   10.12 Absolute $ Opportunity Assessment By Source
   10.13 Market Attractiveness Analysis By Source
   10.14 North America Cannabidiol Market Size Forecast By Application
      10.14.1 Anxiety
      10.14.2 Fibromyalgia
      10.14.3 Diabetes
      10.14.4 Others.
   10.15 Basis Point Share (BPS) Analysis By Application
   10.16 Absolute $ Opportunity Assessment By Application
   10.17 Market Attractiveness Analysis By Application
Chapter 11 Europe Cannabidiol Analysis and Forecast
   11.1 Introduction
   11.2 Europe Cannabidiol Market Size Forecast by Country
      11.2.1 Germany
      11.2.2 France
      11.2.3 Italy
      11.2.4 U.K.
      11.2.5 Spain
      11.2.6 Russia
      11.2.7 Rest of Europe
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Europe Cannabidiol Market Size Forecast By Product Type
      11.6.1 Isolate
      11.6.2 Full Spectrum
      11.6.3 Broad Spectrum
   11.7 Basis Point Share (BPS) Analysis By Product Type
   11.8 Absolute $ Opportunity Assessment By Product Type
   11.9 Market Attractiveness Analysis By Product Type
   11.10 Europe Cannabidiol Market Size Forecast By Source
      11.10.1 Hemp
      11.10.2 Marijuana
   11.11 Basis Point Share (BPS) Analysis By Source
   11.12 Absolute $ Opportunity Assessment By Source
   11.13 Market Attractiveness Analysis By Source
   11.14 Europe Cannabidiol Market Size Forecast By Application
      11.14.1 Anxiety
      11.14.2 Fibromyalgia
      11.14.3 Diabetes
      11.14.4 Others.
   11.15 Basis Point Share (BPS) Analysis By Application
   11.16 Absolute $ Opportunity Assessment By Application
   11.17 Market Attractiveness Analysis By Application
Chapter 12 Asia Pacific Cannabidiol Analysis and Forecast
   12.1 Introduction
   12.2 Asia Pacific Cannabidiol Market Size Forecast by Country
      12.2.1 China
      12.2.2 Japan
      12.2.3 South Korea
      12.2.4 India
      12.2.5 Australia
      12.2.6 South East Asia (SEA)
      12.2.7 Rest of Asia Pacific (APAC)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Asia Pacific Cannabidiol Market Size Forecast By Product Type
      12.6.1 Isolate
      12.6.2 Full Spectrum
      12.6.3 Broad Spectrum
   12.7 Basis Point Share (BPS) Analysis By Product Type
   12.8 Absolute $ Opportunity Assessment By Product Type
   12.9 Market Attractiveness Analysis By Product Type
   12.10 Asia Pacific Cannabidiol Market Size Forecast By Source
      12.10.1 Hemp
      12.10.2 Marijuana
   12.11 Basis Point Share (BPS) Analysis By Source
   12.12 Absolute $ Opportunity Assessment By Source
   12.13 Market Attractiveness Analysis By Source
   12.14 Asia Pacific Cannabidiol Market Size Forecast By Application
      12.14.1 Anxiety
      12.14.2 Fibromyalgia
      12.14.3 Diabetes
      12.14.4 Others.
   12.15 Basis Point Share (BPS) Analysis By Application
   12.16 Absolute $ Opportunity Assessment By Application
   12.17 Market Attractiveness Analysis By Application
Chapter 13 Latin America Cannabidiol Analysis and Forecast
   13.1 Introduction
   13.2 Latin America Cannabidiol Market Size Forecast by Country
      13.2.1 Brazil
      13.2.2 Mexico
      13.2.3 Rest of Latin America (LATAM)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Latin America Cannabidiol Market Size Forecast By Product Type
      13.6.1 Isolate
      13.6.2 Full Spectrum
      13.6.3 Broad Spectrum
   13.7 Basis Point Share (BPS) Analysis By Product Type
   13.8 Absolute $ Opportunity Assessment By Product Type
   13.9 Market Attractiveness Analysis By Product Type
   13.10 Latin America Cannabidiol Market Size Forecast By Source
      13.10.1 Hemp
      13.10.2 Marijuana
   13.11 Basis Point Share (BPS) Analysis By Source
   13.12 Absolute $ Opportunity Assessment By Source
   13.13 Market Attractiveness Analysis By Source
   13.14 Latin America Cannabidiol Market Size Forecast By Application
      13.14.1 Anxiety
      13.14.2 Fibromyalgia
      13.14.3 Diabetes
      13.14.4 Others.
   13.15 Basis Point Share (BPS) Analysis By Application
   13.16 Absolute $ Opportunity Assessment By Application
   13.17 Market Attractiveness Analysis By Application
Chapter 14 Middle East & Africa (MEA) Cannabidiol Analysis and Forecast
   14.1 Introduction
   14.2 Middle East & Africa (MEA) Cannabidiol Market Size Forecast by Country
      14.2.1 Saudi Arabia
      14.2.2 South Africa
      14.2.3 UAE
      14.2.4 Rest of Middle East & Africa (MEA)
   14.3 Basis Point Share (BPS) Analysis by Country
   14.4 Absolute $ Opportunity Assessment by Country
   14.5 Market Attractiveness Analysis by Country
   14.6 Middle East & Africa (MEA) Cannabidiol Market Size Forecast By Product Type
      14.6.1 Isolate
      14.6.2 Full Spectrum
      14.6.3 Broad Spectrum
   14.7 Basis Point Share (BPS) Analysis By Product Type
   14.8 Absolute $ Opportunity Assessment By Product Type
   14.9 Market Attractiveness Analysis By Product Type
   14.10 Middle East & Africa (MEA) Cannabidiol Market Size Forecast By Source
      14.10.1 Hemp
      14.10.2 Marijuana
   14.11 Basis Point Share (BPS) Analysis By Source
   14.12 Absolute $ Opportunity Assessment By Source
   14.13 Market Attractiveness Analysis By Source
   14.14 Middle East & Africa (MEA) Cannabidiol Market Size Forecast By Application
      14.14.1 Anxiety
      14.14.2 Fibromyalgia
      14.14.3 Diabetes
      14.14.4 Others.
   14.15 Basis Point Share (BPS) Analysis By Application
   14.16 Absolute $ Opportunity Assessment By Application
   14.17 Market Attractiveness Analysis By Application
Chapter 15 Competition Landscape
   15.1 Cannabidiol Market: Competitive Dashboard
   15.2 Global Cannabidiol Market: Market Share Analysis, 2019
   15.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
      15.3.1  Canopy Growth Corporation
      15.3.2  Gaia Herbs,
      15.3.3  IRIE CBD
      15.3.4  Isodiol International Inc
      15.3.5 Aurora Cannabis
      15.3.6 Cannoid, Inc.
      15.3.7 CBD American Shaman
      15.3.8 CV Sciences, Inc
      15.3.9 Elixinol
      15.3.10 Endoca.
      15.3.11 FOLIUM BIOSCIENCES
      15.3.12 Medical Marijuana, Inc.
      15.3.13 NuLeaf Naturals, LLC
      15.3.14 PharmaHemp
Key Segments Covered
By Product Type
  • Isolate
  • Full Spectrum
  • Broad Spectrum
By Source
  • Hemp
  • Marijuana
By Application
  • Anxiety
  • Fibromyalgia (FM)
  • Diabetes
  • Others
By Region
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • U.K.
    • France
    • Germany
    • Italy
    • Spain
    • Poland
    • Rest of the Europe
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of MEA
Key Market Players Profiled in the Report
  • Canopy Growth Corporation
  •  Gaia Herbs,
  •  IRIE CBD
  •  Isodiol International Inc,
  • Aurora Cannabis
  • Cannoid, Inc.
  • CBD American Shaman,
  • CV Sciences, Inc.
  • Elixinol
  • Endoca.,
  • FOLIUM BIOSCIENCES
  • Medical Marijuana, Inc.
  • NuLeaf Naturals, LLC
  • PharmaHemp

Buy Report

FAQ Section

Some frequently asked quetions about this report!

Additional company profiles can be provided on request.

Yes, the report covers volume details of products.

According to this Growth Market Reports report, the market from Cannabidiol (CBD) is likely to register a CAGR of approximately 30.4% during forecast period 2020-2027, with an anticipated valuation of US$ 3,420.4 million by the end of the 2027.

In addition to market size (in US$ Million) and Company Market Share (in % for base year 2019), other data such as Macro-economic factors, COVID 19 impact on the market is available in final report.

Rising use of cannabis in several products due to increasing consumer preference for CBD products, approval of pharmaceutical CBD products for several cancer patients to manage pain Increasing usage of CBD in medical applications, skin care products, beverages, and supplements is anticipated to propel market growth and growing disposable income are key factors driving the Cannabidiol (CBD) market growth.

Anxiety are the key end-user that are driving the Cannabidiol (CBD) Market.

Factors such as competitive strength and market positioning are key areas considered while selecting top companies to be profiled.

The market is expected to decline between 2019 and 2020 owing to the slight impact of COVID-19 pandemic on the Cannabidiol (CBD) market. The ongoing research of Cannabidiol (CBD) for COVID-19 string is expected to decrease the production Cannabidiol (CBD) product.

The base year considered for the global Cannabidiol (CBD) Market report is 2019. The complete analysis period is 2017 to 2027, wherein, 2017 & 2018 are the historic years and the forecast is provided from 2021 to 2027.

Major Manufactures include, Canopy Growth Corporation, Gaia Herbs, IRIE CBD, Isodiol International Inc, Aurora Cannabis, Cannoid, Inc., CBD American Shaman, CV Sciences, Inc., Elixinol, Endoca, FOLIUM BIOSCIENCES, Medical Marijuana, Inc., NuLeaf Naturals, LLC PharmaHemp.